Projects and Grants per year
Personal profile
Research Interests
Ovarian cancer; biomarkers; ovarian tumor diagnostics; ovarian ultrasound.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, University Of Kentucky
1995
Doctor of Medicine, Bowman-Gray School Of Medicine
1990
Fingerprint
Dive into the research topics where Frederick Ueland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
GOG-3020/CO-338-087: ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)
Ueland, F. (PI)
Gynecological Oncology Group Foundation Incorporated
11/30/18 → 12/18/25
Project: Research project
-
15-GYN-03-GI (CL-PTL-119) Trial of Maintenance FANG
Ueland, F. (PI)
8/3/15 → 10/6/25
Project: Research project
-
Cell Derived Nanovesicles for Therapeutic Delivery
Kolesar, J. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Richards, C. (CoI) & Ueland, F. (CoI)
10/1/23 → 2/29/24
Project: Research project
-
Jill Kolesar Scope: State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 5
Kolesar, J. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Dwoskin, L. (CoI), Gedaly, R. (CoI), Richards, C. (CoI) & Ueland, F. (CoI)
7/1/22 → 6/30/24
Project: Research project
-
State Matching: Kentucky Network for Innovation & Commercialization (#KYNETIC#) Yr 5
Dwoskin, L. (PI), Arnold, S. (CoI), Bondada, S. (CoI), Lovell, M. (CoI), Prisinzano, T. (CoI), Richards, C. (CoI), Ueland, F. (CoI) & Venditto, V. (CoI)
7/1/22 → 6/30/24
Project: Research project
-
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
Bae-Jump, V. L., Sill, M. W., Gehrig, P. A., Merker, J. D., Corcoran, D. L., Pfefferle, A. D., Hayward, M. C., Walker, J. L., Hagemann, A. R., Waggoner, S. E., O'Cearbhaill, R. E., McDonald, M. E., Edelson, M. I., DiSilvestro, P. A., McNally, A. L., Fleury, A., Littell, R. D., Ueland, F. R., Lankes, H. A. & Aghajanian, C., Apr 2025, In: Gynecologic Oncology. 195, p. 66-74 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
Taylor, S. E., Behr, S., Cooper, K. L., Mahdi, H., Fabian, D., Gallion, H., Ueland, F., Vargo, J., Orr, B., Girda, E., Courtney-Brooks, M., Olawaiye, A. B., Randall, L. M., Richardson, D. L., Sullivan, S. A., Huang, M., Christner, S. M., Beriwal, S., Lin, Y. & Chauhan, A. & 5 others, , Dec 2025, In: Cancer Chemotherapy and Pharmacology. 95, 1, 4.Research output: Contribution to journal › Article › peer-review
-
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
Matei, D. E., Enserro, D. M., Randall, M. E., Mutch, D., Small, W., Disilvestro, P. A., Spirtos, N. M., O'Malley, D. M., Cantuaria, G. H., Michelin, D., Waggoner, S., Shahin, M., Guntupalli, S., Lara, O., Ueland, F. R., Warshal, D., Bonebrake, A., Tewari, K. S., Tan, A. & Powell, M. A. & 4 others, , Mar 20 2025, In: Journal of Clinical Oncology. 43, 9, p. 1055-1060 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Clements, A., Enserro, D., Strickland, K. C., Previs, R., Matei, D., Mutch, D., Powell, M., Klopp, A., Miller, D. S., Small, W., DiSilvestro, P., Spirtos, N., Cosgrove, C., Sfakianos, G., Liu, J. R., Vargas, R., Shahin, M., Corr, B., Dessources, K. & Ueland, F. & 3 others, , Feb 2025, In: Gynecologic Oncology. 193, p. 119-129 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports
Rives, T. A., Collard, J., Li, N., Yan, D., Dietrich, C. S., Miller, R. W., Ueland, F. R., Pickarski, J. & Kolesar, J. M., Sep 1 2024, In: JCO Precision Oncology. 8, e00301.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations